Moonwalk Biosciences Announces $70 Million Series B: NYSE Content Update

NYSE issues a pre-market daily advisory direct from the trading floor.

NEW YORK, Sept. 9, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. 

Kristen Scholer delivers the pre-market update on September 9th

• Moonwalk Bio says recent funding will advance RNAi development.
  • The startup says its treatments have demonstrated reductions in body weight and fat mass while preserving lean muscle mass.
  • Moonwalk's lead development candidate is expected to enter first-in-human clinical studies in late 2027.
  • CEO Dr. Alex Aravanis will join NYSE Live to discuss the path forward for treatments.
• Defense company Covenant opens a 105,000 square-foot factory in Texas.
  • The company introduced Anthem, a heavy-payload, long-range weapon system.
  • Covenant announced more than $250 million in funding across three rounds, with Andreesen Horowitz and Lightspeed among its backers.
• ICE Brent Crude tops $100 a barrel amid the ongoing Middle East conflict.
  • This marks the first time the benchmark has reached triple digits since July.
  • The rise in oil prices comes ahead of a pair of inflation reading, which are set to come out later this week.

Opening Bell
Oracle (NYSE: ORCL) brings together customers for a unique experience

Closing Bell
LabCorp (NYSE: LH) celebrates 35 years as a listed company

For market insights, IPO activity, and today's opening bell, download the NYSE TV App and check out the NYSE YouTube: TV.NYSE.com and YouTube.com/@NYSEofficial

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/moonwalk-biosciences-announces-70-million-series-b-nyse-content-update-302873815.html

SOURCE New York Stock Exchange